Locations:
SearchAdvertisement
Patients who relapse early after first-line chemotherapy are often, but not always, refractory to second-line chemotherapy
Elevated levels of vWF and FVIII associated with risk of blood clots, severe COVID-19 and death
Study matches momelotinib against danazol
Research supports national guidelines for early-stage breast cancer
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Timing of adjuvant immunotherapy unclear for maximum overall survival
Treatment decision must be balanced against toxicity concerns
Genomic adjusted radiation dose guides treatment decision making
Use of tool can change recommendation to add or omit radiation
What is the role of molecular profiling in risk stratification?
Majority of patients achieve complete pathologic response after four-dose cemiplimab therapy
Advertisement
Advertisement